About Firm News
In the News
Lisa Dwyer discusses the impact of the FDA recently publishing more than 200 rejection letters for new drug applications
July 22, 2025
| Law360 Healthcare Authority

Go to the article

Related Capabilities
Innovative Drug, Biologic & Device Development Special Matters & Government Investigations FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
Innovative Drug, Biologic & Device Development
Learn More
a blue and green background
Capabilities
Special Matters & Government Investigations
Learn More